Janssen - Glucose Regulation/Risp/Olanz
NCT00205738
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Type 2 Diabetes Mellitus
Interventions
DRUG:
Risperidone, Olanzapine
Sponsor
Washington University School of Medicine
Collaborators
[object Object]